| |
|
|
|
Brickell Biotech Inc.  
|
|
0.83 -0.012 (-0.01%) |
09-18 16:00 |
|
Open: |
0.85 |
Pre close: |
0.8425 |
Target:
|
1.12
|
|
High: |
0.8699 |
Low: |
0.8212 |
Resistance:
|
0.96
1.11
|
|
Volume: |
600,710 |
Market Cap: |
23M |
Support:
|
0.72
0.60
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.82
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
0.83 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
1.02  |
Stochastic Oscillator |
%K(14,3):
|
35.56 |
|
MA(250): |
1.67 |
%D(3): |
30.37 |
|
Average Volume(K) |
3-Month: |
198614
|
52-Week |
High:
|
4.29 |
|
10-Days: |
165496 |
Low: |
0.71 |
|
RSI |
RSI(14):
|
47.85 |
Change(%): |
-80.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-3.167 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
27.79 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-104.7 |
Shares Float (M) |
24.61 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
14.31 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
-76.4 |
% Held by Institutions |
31.99 |
|
Forward EPS |
-4.500 |
Gross Profit (p.s.) |
-0.443 |
Shares Short (K) |
124 |
|
Book Value (p.s.) |
2.330 |
EBITDA (p.s.) |
-0.919 |
P/E |
-0.26 |
|
Sales Per Share |
0.126 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.36 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-37.77 |
P/S |
6.59 |
|
Operating Margin |
-729.41 |
Levered Free Cash Flow
(M) |
-27.57 |
P/CF |
-0.61 |
|
|
|
|
|
|
